FinanceET Techabout 2 hours ago
Dr Reddy's shares crack 9% after weak Q1
3 min read
Dr Reddy's shares fell 9% to Rs 1,080 on the BSE after reporting a weak Q1. Net profit plunged 69% to Rs 443 crore, while revenue dropped 6% to Rs 8,071 crore. The company faced a Rs 240 crore semaglutide API-related impact. Three brokerages slashed target prices.
Level
Hype check
Tap to vote and see what everyone thinks.
Summary by ByteBrief
